Annual/Quarterly Reports Summary

RL has reported increased revenue and net income over the past three years, driven by favorable foreign currency effects and growth in Asia. Management has implemented initiatives to competitively...

November 8, 2023   RL -0.15%

Nucor is committed to long-term growth and competitiveness, investing in capital expenditures and working capital requirements. They have adequate access to capital markets for liquidity purposes and are monitoring and...

November 8, 2023   NUE 1.22%

Charles River Laboratories International, Inc. has seen an increase in revenue due to higher research model services revenue, small research model sales in all geographic regions, and changes in foreign...

November 8, 2023   CRL 1.36%

VTRS has seen a 3% increase in revenue from 2022 to 2023, driven by an increase in gross sales. Operating expenses have decreased, and the net income margin was...

November 8, 2023   VTRS 0.04%

The company's revenue has increased 4% over the past three years due to higher demand for Biktarvy and channel inventory dynamics. Operating expenses have also increased significantly, with net income...

November 7, 2023   GILD 0.73%

DVA has seen an increase in revenue over the past three years, driven by an increase in U.S. dialysis treatments and non-acquired growth. Operating expenses have decreased and then...

November 7, 2023   DVA 1.23%

Axon is a technology leader in global public safety, with a goal to reduce gun-related deaths by 50% before 2033. Revenue has grown over the past three years, driven by...

November 7, 2023   AXON 0.48%

FMC Corporation is exposed to market risks such as commodity prices, interest rates, and foreign currency exchange rates. To mitigate these risks, they have implemented a risk management...

November 7, 2023   FMC -2.84%

Coterra Energy Inc. reported a 6.1 MMBoe increase in equivalent production for the nine months ended September 30, 2023 compared to the same period in 2022. Revenue has grown steadily...

November 7, 2023   CTRA -5.16%

STE RIS has seen an increase in revenue over the past three years, driven by organic growth in the Healthcare segment and acquisitions. Operating expenses and margins have also...

November 7, 2023   STE 1.49%